LAURIE KEATING - 14 Jun 2023 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Laurie B. Keating
Issuer symbol
IMRX
Transactions as of
14 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 16:44:09 UTC
Previous filing
11 Jan 2023
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +17,500 $0.000000 17,500 14 Jun 2023 Class A Common Stock 17,500 $9.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in substantially equal monthly installments over a one-year period with a vesting commencement date of June 14, 2023, and will be fully vested and exercisable on June 14, 2024, or the date of the 2024 annual meeting of stockholders, whichever comes first.